Charles Schwab’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $232M | Buy |
3,439,164
+263,865
| +8% | +$17.6M | 0.03% | 411 |
|
|
2026
Q1 | $199M | Buy |
3,175,299
+95,988
| +3% | +$6.68M | 0.03% | 425 |
|
|
2025
Q4 | $204M | Sell |
3,079,311
-103,822
| -3% | -$6.71M | 0.03% | 402 |
|
|
2025
Q3 | $214M | Buy |
3,183,133
+109,867
| +4% | +$8.69M | 0.03% | 392 |
|
|
2025
Q2 | $268M | Buy |
3,073,266
+95,710
| +3% | +$7.5M | 0.05% | 318 |
|
|
2025
Q1 | $203M | Buy |
2,977,556
+152,350
| +5% | +$12.4M | 0.04% | 376 |
|
|
2024
Q4 | $220M | Buy |
2,825,206
+91,051
| +3% | +$6.74M | 0.04% | 359 |
|
|
2024
Q3 | $183M | Buy |
2,734,155
+288,381
| +12% | +$23.7M | 0.04% | 398 |
|
|
2024
Q2 | $277M | Buy |
2,445,774
+115,472
| +5% | +$14.6M | 0.05% | 292 |
|
|
2024
Q1 | $323M | Buy |
2,330,302
+88,601
| +4% | +$11.1M | 0.07% | 233 |
|
|
2023
Q4 | $278M | Buy |
2,241,701
+80,740
| +4% | +$8.25M | 0.07% | 246 |
|
|
2023
Q3 | $202M | Buy |
2,160,961
+28,621
| +1% | +$3.23M | 0.06% | 300 |
|
|
2023
Q2 | $274M | Buy |
2,132,340
+24,599
| +1% | +$2.98M | 0.08% | 215 |
|
|
2023
Q1 | $245M | Buy |
2,107,741
+34,199
| +2% | +$3.83M | 0.07% | 227 |
|
|
2022
Q4 | $235M | Buy |
2,073,542
+38,958
| +2% | +$4.28M | 0.08% | 239 |
|
|
2022
Q3 | $164M | Buy |
2,034,584
+46,651
| +2% | +$3.95M | 0.06% | 299 |
|
|
2022
Q2 | $148M | Buy |
1,987,933
+62,957
| +3% | +$5.75M | 0.05% | 329 |
|
|
2022
Q1 | $246M | Buy |
1,924,976
+53,352
| +3% | +$5.84M | 0.07% | 249 |
|
|
2021
Q4 | $251M | Buy |
1,871,624
+47,772
| +3% | +$6.86M | 0.07% | 236 |
|
|
2021
Q3 | $249M | Buy |
1,823,852
+33,924
| +2% | +$4.28M | 0.08% | 215 |
|
|
2021
Q2 | $191M | Buy |
1,789,928
+69,452
| +4% | +$6.67M | 0.06% | 276 |
|
|
2021
Q1 | $155M | Buy |
1,720,476
+25,904
| +2% | +$2.43M | 0.06% | 305 |
|
|
2020
Q4 | $157M | Sell |
1,694,572
-54,176
| -3% | -$4.84M | 0.06% | 282 |
|
|
2020
Q3 | $180M | Buy |
1,748,748
+110,068
| +7% | +$11.5M | 0.08% | 213 |
|
|
2020
Q2 | $166M | Buy |
1,638,680
+662,124
| +68% | +$59.2M | 0.08% | 225 |
|
|
2020
Q1 | $65.7M | Sell |
976,556
-12,040
| -1% | -$749K | 0.04% | 420 |
|
|
2019
Q4 | $54.1M | Sell |
988,596
-10,632
| -1% | -$504K | 0.03% | 577 |
|
|
2019
Q3 | $37.3M | Sell |
999,228
-756,756
| -43% | -$29.4M | 0.02% | 746 |
|
|
2019
Q2 | $65.8M | Buy |
1,755,984
+53,792
| +3% | +$1.69M | 0.04% | 441 |
|
|
2019
Q1 | $50.7M | Buy |
1,702,192
+282,280
| +20% | +$9.92M | 0.03% | 537 |
|
|
2018
Q4 | $42.5M | Buy |
1,419,912
+67,204
| +5% | +$2.13M | 0.03% | 529 |
|
|
2018
Q3 | $48.4M | Buy |
1,352,708
+78,524
| +6% | +$2.43M | 0.03% | 546 |
|
|
2018
Q2 | $30.3M | Buy |
1,274,184
+93,156
| +8% | +$1.98M | 0.02% | 777 |
|
|
2018
Q1 | $21.9M | Buy |
1,181,028
+129,972
| +12% | +$1.92M | 0.02% | 939 |
|
|
2017
Q4 | $15.1M | Sell |
1,051,056
-9,020
| -0.9% | -$117K | 0.01% | 1189 |
|
|
2017
Q3 | $13M | Buy |
1,060,076
+32,684
| +3% | +$578K | 0.01% | 1221 |
|
|
2017
Q2 | $18.8M | Buy |
1,027,392
+118,432
| +13% | +$2.19M | 0.02% | 891 |
|
|
2017
Q1 | $19.3M | Buy |
908,960
+27,252
| +3% | +$532K | 0.02% | 851 |
|
|
2016
Q4 | $13.2M | Buy |
881,708
+54,612
| +7% | +$967K | 0.01% | 1064 |
|
|
2016
Q3 | $18.1M | Buy |
827,096
+35,240
| +4% | +$784K | 0.02% | 750 |
|
|
2016
Q2 | $15.7M | Buy |
791,856
+65,192
| +9% | +$1.11M | 0.02% | 782 |
|
|
2016
Q1 | $12.3M | Buy |
726,664
+27,084
| +4% | +$452K | 0.02% | 907 |
|
|
2015
Q4 | $14.3M | Buy |
699,580
+58,948
| +9% | +$1.23M | 0.02% | 793 |
|
|
2015
Q3 | $13.8M | Buy |
640,632
+77,976
| +14% | +$1.74M | 0.02% | 761 |
|
|
2015
Q2 | $11.3M | Sell |
562,656
-404,252
| -42% | -$7.1M | 0.02% | 942 |
|
|
2015
Q1 | $15.1M | Buy |
966,908
+167,180
| +21% | +$2.53M | 0.02% | 727 |
|
|
2014
Q4 | $11M | Buy |
799,728
+10,028
| +1% | +$123K | 0.02% | 819 |
|
|
2014
Q3 | $7.9M | Buy |
789,700
+24,688
| +3% | +$252K | 0.01% | 1007 |
|
|
2014
Q2 | $7.59M | Buy |
765,012
+11,672
| +2% | +$103K | 0.01% | 1051 |
|
|
2014
Q1 | $7.79M | Buy |
753,340
+43,004
| +6% | +$444K | 0.01% | 989 |
|
|
2013
Q4 | $6.29M | Buy |
710,336
+42,524
| +6% | +$337K | 0.01% | 1073 |
|
|
2013
Q3 | $4.7M | Buy |
667,812
+12,344
| +2% | +$78.2K | 0.01% | 1231 |
|
|
2013
Q2 | $3.74M | Buy |
+655,468
| New | +$3.14M | 0.01% | 1300 |
|
Other funds holding DXCM
Charles Schwab's DXCM Position: Q2 2026 in Review
Charles Schwab increased its DexCom (DXCM) stake by 8.3% in Q2 2026, buying an estimated $17.6M and bringing the position to 3,439,164 shares worth $232M. The position accounts for 0.03% of the portfolio, ranked #411.
Charles Schwab first reported a position in DXCM in Q2 2013 and has held it in 53 quarters since. The position peaked at $323M in Q1 2024. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- Charles Schwab held 3,439,164 shares of DexCom worth $232M as of Q2 2026.
- Charles Schwab bought 263,865 DexCom shares in Q2 2026, an estimated $17.6M.
- DexCom made up 0.03% of Charles Schwab's portfolio in Q2 2026, its #411 holding.
- Charles Schwab first reported a position in DexCom in Q2 2013 and has held it in 53 quarters since.
- Charles Schwab's DexCom position peaked at $323M in Q1 2024.
- 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.